Conceptio
›
t-cells
Topic
t-cells
Knowledge-graph topic
· documents ABOUT t-cells across the archive
50
Documents about t-cells
Documents about t-cells
Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function
#884827
ClinicalTrials.gov
TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia
#887058
ClinicalTrials.gov
γδT Cells Immunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)
#1031670
ClinicalTrials.gov
Systematically optimized BCMA/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma
#609399
eScholarship
A Safety and Efficacy Trial of JCAR017 Combinations in Subjects With Relapsed/Refractory B-cell Malignancies
#898600
ClinicalTrials.gov
Pembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate Cancer
#993414
ClinicalTrials.gov
Study of the Association Between Fatigue Experienced by Patients and the Specific Side Effects of CART Cells, During the First Month After Administration for Non-Hodgkin's Lymphoma
#184870
ClinicalTrials.gov
Investigator Initiated Study to Assess the Safety of Combination of CLS-015 With Anti-CD-19 CAR-T Cells in Patients With Stable/Progressive Large B Cell Lymphoma at Lymphodepletion.
#800627
ClinicalTrials.gov
Allogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells (CD6-CAR Tregs) for the Treatment of Patients With Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation
#28336
ClinicalTrials.gov
Autologous T Cells and Cyclophosphamide in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Cannot Be Removed By Surgery
#121371
ClinicalTrials.gov
CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies
#217035
ClinicalTrials.gov
Central memory CD4+ T cells are preferential targets of double infection by HIV-1 Retroviruses
#220231
UNSWorks Repository
Dual targeting of solid tumors using cytokine-induced killer cells modified with a CAR anti-tenascin C and a secretable EGFRxCD3 bispecific antibody
#202774
IRIS
T Cells Promote Bronchial Epithelial Cell Secretion of Matrix Metalloproteinase-9 via a C-C Chemokine Receptor Type 2 Pathway: Implications for Chronic Lung Allograft Dysfunction
#268703
HAL (France)
Resveratrol Attenuates Allergic Asthma and Associated Inflammation in the Lungs Through Regulation of miRNA-34a That Targets FoxP3 in Mice
#637536
Scholar Commons
Study of Redirected Autologous T Cells Engineered to Contain Anti-CD19 Attached to TCR and 4-1BB Signaling Domains in Patients With Chemotherapy Resistant or Refractory Acute Lymphoblastic Leukemia
#889952
ClinicalTrials.gov
Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection
#491768
eScholarship
Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4+ T cells
#492118
eScholarship
Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor Malignancies
#885090
ClinicalTrials.gov
Coupled effects of catalyst–ionomer ratio and hot-press load on the performance of proton exchange membrane fuel cells
#940708
Journal of Thermal Engineering
Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer
#148747
ClinicalTrials.gov
Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Inducing Neutralizing Antibodies in COVID -19 Infected Patients Better Than Vaccine : An Innovative Treatment
#855689
ClinicalTrials.gov
Study of CD19/CD22 Chimeric Antigen Receptor T Cells in Children & Young Adults w/ Recurrent or Refractory B Cell Malignancies
#966179
ClinicalTrials.gov
A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
#835171
ClinicalTrials.gov
A First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Intravenous (IV) Dose of GSK2831781 in Healthy Volunteers and Patients With Plaque Psoriasis
#847394
ClinicalTrials.gov
This is a Phase I/II Interventional, Open-label Treatment Study Designed to Evaluate the Safety and Efficacy of Anti CD 19/22 CAR- T Cells Immunotherapy for Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia/Lymphoma.
#67863
ClinicalTrials.gov
Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCT
#877059
ClinicalTrials.gov
Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Control the Immune Hyperactivation Associated With COVID-19 and/or Acute Respiratory Distress Syndrome (THYTECH2)
#891864
ClinicalTrials.gov
CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR)
#861685
ClinicalTrials.gov
HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies
#911752
ClinicalTrials.gov
Genetically Modified T-Cells Followed by Aldesleukin in Treating Patients With Stage III-IV Melanoma
#136343
ClinicalTrials.gov
A Phase I Interventional Open-label, Non-randomized Dose-escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Preliminary Anti-tumor Activity of Autologous p95HER2.CAR-TECH2Me T Cells in Patients With Selected Advanced Cancers.
#831884
ClinicalTrials.gov
A Phase-I, Dose Escalation Study of Recombinant Human Interleukin-18 (Sb-485232) Combined With Adoptive Transfer of Vaccine-Primed CD3/CD28-Costimulated Autologous T-Cells Following Lymphodepletion for Adult Patients With Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer
#969213
ClinicalTrials.gov
Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant
#407722
ClinicalTrials.gov
Image 2_Comparative efficacy and safety of traditional Chinese medicine injections combined with chemotherapy for advanced non-small cell lung cancer: a Bayesian network meta-analysis.tif
#464145
Figshare
Image 1_Comparative efficacy and safety of traditional Chinese medicine injections combined with chemotherapy for advanced non-small cell lung cancer: a Bayesian network meta-analysis.tif
#464146
Figshare
HIV efficiently infects T cells from the endometrium and remodels them to promote systemic viral spread
#609389
eScholarship
Tissue memory CD4+ T cells expressing IL-7 receptor-alpha (CD127) preferentially support latent HIV-1 infection
#609404
eScholarship
Low-dose allergen targeting to cDC2 induces long-term protection associated with induction of regulatory-like IL-10+ Foxp3- CD8+ T cells in mice / Arpa Aintablian, Laura Cyran, Moutaz Helal, Christian H.K. Lehmann, Fabian Imdahl, Tom Gräfenhan, Angela Riedel, Diana Dudziak, Andreas Kerstan, Manfred B. Lutz
#675555
Deutsche Nationalbibliothek
Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma
#307460
ClinicalTrials.gov
Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant
#833919
ClinicalTrials.gov
Treg Modulation With CD28 and IL-6 Receptor Antagonists
#993218
ClinicalTrials.gov
Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer
#852972
ClinicalTrials.gov
CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
#992861
ClinicalTrials.gov
Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infection or Associated Diseases Following Anticancer Therapy or Allogeneic Hematopoietic Stem Cell Transplantation.
#892744
ClinicalTrials.gov
Elucidating the origin of open‐circuit voltage in ternary organic solar cells with a nonfullerene and a fullerene acceptor / Dominic Blätte, Marcella Günther, Carlito S. Ponseca, Andreas Weis, Rik Hooijer, Lucie Quincke, Miguel A. T. Cachafeiro, Wolfgang Tress, Jose D. Perea, Salvador Leon, Ali Shuaib, Pavel Chabera, Tönu Pullerits, Thomas Bein, Tayebeh Ameri
#814174
Deutsche Nationalbibliothek
A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas
#300255
ClinicalTrials.gov
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
#492031
eScholarship
Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion)
#806979
ClinicalTrials.gov
MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer
#826793
ClinicalTrials.gov
← Previous
Page 18 of 19
Next →
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.